Thomas W. Elrod

• Name Teladoc Health, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Teladoc Health, Inc. (“Teladoc” or the “Company”) (NYSE:TDOC). The investigation concerns whether Teladoc and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name TFI International Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against TFI International Inc. (“TFI” or the “Company”) (NYSE:TFII). The investigation concerns whether TFI and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Alarum Technologies Ltd.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired Alarum Technologies Ltd. (“Alarum” or the “Company”) (NASDAQ:ALAR) securities during the period from March 14, 2024, through August 26, 2024 (“the Class Period”). Investors have until April 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Constellation Brands, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of New York on behalf of those who acquired Constellation Brands, Inc. (“Constellation” or the “Company”) (NYSE:STZ) securities during the period from April 11, 2024, through January 8, 2025 (“the Class Period”). Investors have until April 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name FMC Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired FMC Corporation (“FMC” or the “Company”) (NYSE:FMC) securities during the period from November 16, 2023, through February 4, 2025 (“the Class Period”). Investors have until April 14, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Merck & Co.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired Merck & Co. (“Merck” or the “Company”) (NYSE:MRK) securities during the period from February 3, 2022, through February 3, 2025 (“the Class Period”). Investors have until April 14, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Parsons Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Parsons Corporation (“Parsons” or the “Company”) (NYSE:PSN). The investigation concerns whether Parsons and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name The Trade Desk, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired The Trade Desk, Inc. (“Trade Desk” or the “Company”) (NASDAQ:TTD) securities during the period from May 9, 2024, through February 12, 2025 (“the Class Period”). Investors have until April 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name AMC Networks Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against AMC Networks Inc. (“AMC” or the “Company”) (NASDAQ:AMCX). The investigation concerns whether AMC and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Edison International
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired Edison International (“Edison” or the “Company”) (NYSE:EIX) securities during the period from February 25, 2021, through February 6, 2025 (“the Class Period”). Investors have until April 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Septerna, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Septerna, Inc. (“Septerna” or the “Company”) (NASDAQ:SEPN). The investigation concerns whether Septerna and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Voyager Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Voyager Therapeutics, Inc. (“Voyager” or the “Company”) (NASDAQ:VYGR). The investigation concerns whether Voyager and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Everus Construction Group, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Everus Construction Group, Inc. (“Everus” or the “Company”) (NYSE:ECG). The investigation concerns whether Everus and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Perpetua Resources Corp.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Perpetua Resources Corp. (“Perpetua” or the “Company”) (NASDAQ:PPTA). The investigation concerns whether Perpetua and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name TransMedics Group, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQ:TMDX) securities during the period from February 28, 2023, through January 10, 2025 (“the Class Period”). Investors have until April 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Venture Global, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Venture Global, Inc. (“Venture” or the “Company”) (NYSE:VG): common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2025 initial public offering (“IPO”). Investors have until April 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Neumora Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQ:NMRA): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s September 2023, initial public offering (“IPO” or the “Offering”). Investors have until April 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Elastic N.V.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired Elastic N.V. (“Elastic” or the “Company”) (NYSE:ESTC) securities during the period from May 31, 2024, through August 29, 2024 (“the Class Period”). Investors have until April 14, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name ICON plc
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of New York on behalf of those who acquired ICON Public Limited Company (“ICON” or the “Company”) (NASDAQ:ICLR) securities during the period from July 27, 2023, through October 23, 2024 (“the Class Period”). Investors have until April 11, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Skyworks Solutions, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Skyworks Solutions, Inc. (“Skyworks” or the “Company”) (NASDAQ:SWKS). The investigation concerns whether Skyworks and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Semtech Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Semtech Corporation (“Semtech” or the “Company”) (NASDAQ:SMTC). The investigation concerns whether Semtech and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name GSK PLC
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Pennsylvania on behalf of those who acquired GSK PLC (“GSK” or the “Company”) (NYSE:GSK) securities during the period from February 5, 2020, through August 14, 2022 (“the Class Period”). Investors have until April 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Monolithic Power Systems, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Washington on behalf of those who acquired Monolithic Power Systems, Inc. (“Monolithic” or the “Company”) (NASDAQ:MPWR) securities during the period from February 8, 2024, through November 8, 2024 (“the Class Period”). Investors have until April 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Newmont Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Colorado on behalf of those who acquired Newmont Corporation (“Newmont” or the “Company”) (NYSE:NEM) securities during the period from February 22, 2024, through October 23, 2024 (“the Class Period”). Investors have until April 1, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Polestar Automotive Holding UK PLC
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired Polestar Automotive Holding UK PLC (“Polestar” or the “Company”) (NASDAQ:PSNY) securities during the period from November 14, 2022, through January 16, 2025 (“the Class Period”). Inves-tors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Target Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Florida on behalf of those who acquired Target Corporation (“Target” or the “Company”) (NYSE:TGT) securities during the period from Au-gust 26, 2022, through November 19, 2024 (“the Class Period”). Investors have until April 1, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Walgreens Boots Alliance, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois on behalf of those who acquired Walgreens Boots Alliance, Inc. (“Walgreens” or the “Company”) (NASDAQ:WBA) securities during the period from April 2, 2020, through January 16, 2025 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Grocery Outlet Holding Corp.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Grocery Outlet Holding Corp. (“Grocery Outlet” or the “Company”) (NASDAQ:GO) securities during the period from November 7, 2023, through May 7, 2024 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name TELUS International (Cda) Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired TELUS International (Cda) Inc. (“TELUS” or the “Company”) (NYSE:TIXT) securities during the period from February 16, 2024, through August 1, 2024 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Arconic Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who sold Arconic Corporation (“Arconic” or the “Company”) (NYSE:ARNC) common stocks during the period from April 19, 2022, through May 3, 2023 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Integral Ad Science Holding Corp.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQ:IAS) securities during the period from March 2, 2023, through February 27, 2024 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Construction Partners, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Construction Part-ners, Inc. (“ROAD” or the “Company”) (NASDAQ:ROAD). The investigation concerns whether ROAD and/or certain of its officers have violated the federal securities laws and/or engaged in oth-er unlawful business practices.

• Name ModivCare, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Colorado on behalf of those who acquired ModivCare, Inc. (“ModivCare” or the “Company”) (NASDAQ:MODV) securities during the period from November 3, 2022, through September 15, 2024 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Novo Nordisk A/S
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of those who acquired Novo Nordisk A/S (“Novo” or the “Company”) (NYSE:NVO) securities during the period from November 2, 2022, through December 19, 2024 (“the Class Period”). Investors have until March 25, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Triumph Financial, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Triumph Financial, Inc. (“Triumph” or the “Company”) (NASDAQ:TFIN). The investigation concerns whether Triumph and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Cardlytics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Georgia on behalf of those who acquired Cardlytics, Inc. (“Cardlytics” or the “Company”) (NASDAQ:CDLX) securities during the period through March 14, 2024, through August 7, 2024 (“the Class Period”). Investors have until March 25, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.  

• Name Clear Secure, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Clear Secure, Inc. (“Clear” or the “Company”) (NYSE:YOU). The investigation concerns whether Clear and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name ESSA Pharma Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Wisconsin on behalf of those who acquired ESSA Pharma Inc. (“ESSA” or the “Company”) (NASDAQ:EPIX) securities during the period from December 12, 2023, through October 31, 2024 (“the Class Period”). Investors have until March 25, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Crocs, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Delaware on behalf of those who acquired Crocs, Inc. (“Crocs” or the “Company”) (NASDAQ:CROX) securities during the period from November 3, 2022, through October 28, 2024 (“the Class Period”). Investors have until March 24, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Block, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Block, Inc. (“Block” or the “Company”) (NYSE:SQ) securities during the period from February 26, 2020, through April 30, 2024 (“the Class Period”). Investors have until March 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name FTAI Aviation Ltd.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired FTAI Aviation Ltd. (“FTAI” or the “Company”) (NASDAQ:FTAI) securities during the period from July 23, 2024, through January 15, 2025 (“the Class Period”). Investors have until March 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Keros Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Keros Therapeutics, Inc. (“Keros” or the “Company”) (NASDAQ:KROS). The investigation concerns whether Keros and/or certain of its officers have violated the federal securities laws and/or engaged in other un-lawful business practices.

• Name Innovative Industrial Properties, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Maryland District Court on behalf of those who acquired Innovative Industrial Properties, Inc. (“IIPR” or the “Company”) (NYSE:IIPR) securities during the period from February 27, 2024, through December 19, 2024 (“the Class Period”). Investors have until March 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Micron Technology, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of those who acquired Micron Technology, Inc. (“Micron” or the “Company”) (NASDAQ:MU) securities during the period from September 28, 2023, through December 18, 2024 (“the Class Period”). Investors have until March 10, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Pacira Biosciences, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for New Jersey on behalf of those who acquired Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ:PCRX) securities during the period from August 2, 2023, through August 8, 2024 (“the Class Period”). Investors have until March 14, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Dave Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Dave Inc. (“Dave” or the “Company”) (NASDAQ:DAVE). The investigation concerns whether Dave and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name BioAge Labs, Inc.
• Type Securities
• Status Investigating
• he law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQ:BIOA) securities during the period from September 22, 2024, through January 7, 2025 (“the Class Period”). Investors have until March 10, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Regeneron Pharmaceuticals, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ:REGN) securities during the period of November 2, 2023, to October 30, 2024, inclusive (“the Class Period”). Investors have until March 10, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Revance Therapeutics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of those who acquired Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQ:RVNC) securities during the period from February 29, 2024, through December 6, 2024 (“the Class Period”). Investors have until March 4, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Silvaco Group, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Silvaco Group, Inc. (“Silvaco” or the “Company”) (NASDAQ:SVCO). The investigation concerns whether Silvaco and/or certain of its officers have violated the federal securities laws and/or engaged in other un-lawful business practices.

• Name Sezzle Inc.
• Type Securities
• Status Investigating
• December 31, 2024, NEW YORK—(GLOBE NEWSWIRE)—The law firm of Kirby McInerney LLP is investigating potential claims against Sezzle Inc. (“Sezzle” or the “Company”) (NASDAQ:SEZL). The investigation concerns whether Sezzle and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Caribou Bioscience, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Caribou Bioscience, Inc. (“Caribou” or the “Company”) (NASDAQ:CRBU) securities during the period of July 14, 2023, to July 16, 2024, inclusive (“the Class Period”). Investors have until February 24, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Nextracker Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQ:NXT) securities during the period from February 1, 2024, through August 1, 2024 (“the Class Period”). Investors have until February 25, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Transocean Ltd.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Transocean Ltd. (“Transocean” or the “Company”) (NYSE:RIG) securities during the period from October 31, 2023 through September 2, 2024 (“the Class Period”). Investors have until February 24, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

• Name Quanterix Corporation
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Quanterix Corporation (“Quanterix” or the “Company”) (NASDAQ: QTRX). The investigation concerns whether Quanterix and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name Huntington Ingalls Industries, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP announces that it is investigating potential claims against Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NYSE: HII). The investigation concerns whether Huntington Ingalls and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name MediaAlpha, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (NYSE: MAX) The investigation concerns whether MediaAlpha and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name ADMA Biologics, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA). The investigation concerns whether ADMA and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Aviat Networks, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Aviat Networks, Inc. (“Aviat” or the “Company”) (NASDAQ: AVNW). The investigation concerns whether Aviat and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Napco Security Technologies, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Napco Security Technologies, Inc. (“Napco” or the “Company”) (NASDAQ: NSSC). The investigation concerns whether Napco and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Franklin Resources, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Franklin Resources, Inc. (“Franklin” or the “Company”) (NASDAQ: BEN). The investigation concerns whether Franklin and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Medpace Holdings, Inc
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Medpace Holdings, Inc. (“Medpace” or the “Company”) (NASDAQ: MEDP). The investigation concerns whether Medpace and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.
   

• Name Inspired Entertainment, Inc.
• Type Securities
• Status Investigating
• The law firm of Kirby McInerney LLP is investigating potential claims against Inspired Entertainment, Inc. (“Inspired Entertainment” or the “Company”) (NYSE: INSE). The investigation concerns whether Inspired Entertainment and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

• Name CFTC v. Shak,
  No. 14-cv-01632 (D.D.C.).  
• Type Commodities
• Status Pending
• Representation of a defendant in a case brought by the CFTC under the Commodity Exchange Act’s newest provisions for violations of an administrative order in the gold futures market.

• Name In re Cattle Antitrust Litigation,
  No. 19-cv-1222 (D. Minn.).
• Type Commodities
• Status Pending
• Court-appointed executive committee member and class counsel representing cattle producers and cattle futures traders in a lawsuit alleging that the “Big 4” meatpacking firms conspired to suppress prices for fed cattle and manipulated live cattle futures traded on the Chicago Mercantile Exchange.

• Name Dufoe v. DraftKings Inc., et al, 23-cv-10524 (D.Mass.). 
• Type Securities
• Status Pending
• Lead counsel to a class of investors that purchased non-fungible tokens (NFTs) from DraftKings Inc., which operates as a daily fantasy sports contest and sports betting company. The case alleges that DraftKings sold unregistered securities and ensured that money stayed on DraftKings’ private and exclusively controlled marketplace, propping up the market for an overall valuation of DraftKings’ NFTs and significantly harming investors.  

• Name Macovski v. Groupon Inc.,
  No. 20-cv-2581 (N.D. Ill.).
• Type Securities
• Status Settled
• We acted as co-lead counsel in this securities class action alleging that the company made materially false and misleading statements and failed to disclose to investors its financial health before ending its sale of physical goods and announcing the departure of two top executives. The case resulted in a $13.5 million settlement that has received final approval.

• Name In re JPMorgan Treasury Futures Spoofing Litigation, 
  No. 20-cv-03515 (S.D.N.Y.).
• Type Antitrust, Commodities
• Status Settled
• Lead counsel in an antitrust case alleging that J.P. Morgan unlawfully and intentionally manipulated U.S. Treasury Futures or Options on U.S. Treasury Futures traded on United States-based exchanges, including but not limited to the Chicago Mercantile Exchange, including its subsidiary the Chicago Board of Trade, during the Class Period in violation of the Commodity Exchange Act, 7 U.S.C. §§ 1, et seq. (the “CEA”) and the common law.  The case resulted in a settlement of $15.7 million.

• Name Doyle v. Reata Pharmaceuticals, Inc.,
  No. 21-cv-00987 (E.D. Tex.).
• Type Securities
• Status Settled
• We are representing Wespath, the General Board of Pension and Health Benefits of the United Methodist Church, in this securities class action alleging that Reata Pharmaceuticals made false and/or misleading statements — including in connection with its secondary public stock offerings — concerning, inter alia, the FDA guidance regarding the design of the clinical trial (CARDINAL) for Reata’s drug candidate, bardoxolone methyl. When the FDA revealed serious concerns it had previously raised to Reata, the share price declined materially.  The case has resulted in a settlement of $45 million.

• Name CFTC Whistleblower Award,
  No. 21-WB-07
• Type Antitrust, CFTC Whistleblower, Commodities, False Claims Act, Whistleblower
• Status Settled
• KM represented the whistleblower who received nearly $200 million, the largest CFTC whistleblower award ever and the second largest whistleblower award arising under the Dodd-Frank and IRS whistleblower programs. The information the whistleblower provided catalyzed investigations by the Commodity Futures Trading Commission (CFTC), a U.S. federal regulator, and a foreign regulator into the manipulation of crucial financial benchmarks used by global banks as the basis for the pricing of fixed income securities and derivative products.  The CFTC initially rejected the whistleblower’s award application, but KM's advocacy resulted in a successful appeal for the client.

• Name Kokareva v. Bristow Group Inc., 
  No. 19-cv-00509 (S.D. Tex.).
• Type Securities
• Status Settled
• We acted as co-lead counsel in this securities class action alleging that an aviation services provider, focused on the oil and gas sector, made materially false and misleading statements about its internal controls relating to covenants in the company’s secured financing agreements. The case resulted in a $6.25 million settlement that has received final approval.

• Name In re Foreign Exchange Benchmark Rates Antitrust Litigation, 
  No. 13-cv-07789 (S.D.N.Y.).
• Type Antitrust, Commodities
• Status Settled
• Special fiduciary representation for the exchange-based class for a putative class of participants who traded futures and options in the FX market. The case has already resulted in partial settlements of more than $2.3 billion.

• Name In re Resonant Inc. Securities Litigation,
  No. 15-cv-01970 (C.D. Cal.).
• Type Securities
• Status Settled
• In re Resonant Inc. Securities Litigation, No. 15-cv-01970 (C.D. Cal. 2017).  Co-lead counsel.  $2.75 million settlement.

• Name Rothstein v. GMAC Mortgage LLC,
  No. 12-cv-03412 (S.D.N.Y.).
• Type Consumer Fraud
• Status Settled
• Rothstein v. GMAC Mortgage LLC, No. 12-cv-03412 (S.D.N.Y.).  Lead counsel.  $13 million settlement against GMAC Mortgage LLC in In re Residential Capital, LLC, No. 12-12020 (Bankr. S.D.N.Y. 2016).

• Name In re Hi-Crush Partners L.P. Securities Litigation,
  No. 12-cv-08557 (S.D.N.Y.).  
• Type Securities
• Status Settled
• In re Hi-Crush Partners L.P. Securities Litigation, No. 12-cv-08557 (S.D.N.Y. 2015).  Lead counsel.  $3.8 million settlement while class certification was pending.

• Name In re LIBOR-Based Financial Instruments Antitrust Litigation,
  No. 11-md-02262 (S.D.N.Y.). 
• Type Antitrust, Commodities
• Status Settled
• KM acted as court-appointed co-liaison counsel for all class actions in the multi-district litigation and co-lead counsel for exchange-based class in the high-profile In re Libor-Based Financial Instruments Antitrust Litigation and FTC Capital GMBH et al. v. Credit Suisse Group AG et al. alleging the fixing of prices of a benchmark interest rate.  The case resulted in settlements totaling $190.45 million, which combined represent the largest recovery in a “futures-only” commodities class action litigation.

• Name In re Citigroup Inc Securities Litigation, 
  No. 07-cv-09901 (S.D.N.Y.).  
• Type Securities, Structured Finance
• Status Settled
• Lead counsel for individual investor lead plaintiffs in this securities fraud class action relating to Citigroup’s exposure to losses associated with its creation or sponsorship of numerous collateralized debt obligations (“CDOs”).  This case resulted in a settlement of $590 million for the class.  The settlement was, at the time, the largest CDO-related settlement ever, as well as the largest settlement of a fraud-only action.  A later filed SEC complaint concerning similar allegations settled for a small fraction of the class action settlement amount.